Gilde Healthcare exits stake in Stat-Dx for $147m
Gilde Healthcare has exited its stake in Spanish molecular diagnostics business Stat-Dx for $147m (€122.9m), with additional cash payments of up to $44m depending on the achievement of regulatory and commercial milestones.
Gilde